Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9954440 | 0.76 | NFE2L2 (0.44) | — | |
| SCHEMBL16651 | 0.75 | CYP2C19 (0.42) | CYP2A6ALDH1A1HPGDRAB9ACYP2C19 | |
| SCHEMBL8046808 | 0.74 | HSD17B10 (0.46) | CYP2A6ALDH1A1NPC1MAPTMAOB | |
| SCHEMBL6475121 | 0.70 | KIF11 (0.50) | ALDH1A1CA1MAPK1MEN1MAPT | |
| SCHEMBL209252 | 0.69 | — | — | |
| SCHEMBL2583922 | 0.69 | — | — | |
| SCHEMBL8059285 | 0.69 | ALDH1A1 (0.52) | CYP2A6ALDH1A1HPGDRAB9ACYP2C19 | |
| SCHEMBL9679607 | 0.67 | ALDH1A1 (0.61) | CYP2A6ALDH1A1HPGDRAB9ACYP2C19 | |
| SCHEMBL5248678 | 0.67 | CYP2A6 (0.57) | CYP2A6ALDH1A1HPGDRAB9ACYP2C19 | |
| SCHEMBL9679616 | 0.67 | ALDH1A1 (0.61) | CYP2A6ALDH1A1HPGDRAB9ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | claimed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2017-06-22 | — | — | US | disclosed |
| US-9583719-B2 | Carbazolocarbazol-bis(dicarboximides) and their use as semiconductors | BASF SE (DE) | 2017-02-28 | — | — | US | disclosed |
| US-9512354-B2 | Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics | BASF SE (DE) | 2016-12-06 | — | — | US | disclosed |
| US-9385326-B2 | Triangulene oligomers and polymers and their use as hole conducting material | BASF SE (DE) | 2016-07-05 | — | — | US | disclosed |
| EP-2742112-B1 | CARBAZOLOCARBAZOL-BIS(DICARBOXIMIDES) AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| EP-2976340-A1 | CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2016-01-27 | — | — | EP | disclosed |
| EP-2946420-A1 | TRIANGULENE OLIGOMERS AND POLYMERS AND THEIR USE AS HOLE CONDUCTING MATERIAL | BASF SE (DE) | 2015-11-25 | — | — | EP | disclosed |
| US-20150333275-A1 | TRIANGULENE OLIGOMERS AND POLYMERS AND THEIR USE AS HOLE CONDUCTING MATERIAL | BASF SE (DE) | 2015-11-19 | — | — | US | disclosed |
| CN-100430052-C | Cathepsin cysteine protease inhibitors | MERCK FROSST CANADA INC (CA) | 2008-11-05 | — | — | CN | disclosed |
| EP-1966206-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2008-09-10 | — | — | EP | disclosed |
| US-20080090325-A1 | METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-17 | — | — | US | disclosed |
| US-20080017850-A1 | applying n-type organic semiconducting compound 1,6,7,12-Tetrachloro-N,N'-benzyl-perylene-3,9; 11,12-tetracarboxylic diimide or 1,6,7,12-tetrachloroperylen-3,9; 9,10-tetracarboxylic dianhydride; charge transfer compounds for electronics, optoelectronics and photonic applications; chemical intermediates | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-24 | — | — | US | disclosed |
| WO-2007128774-A1 | METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS | BASF SE (DE) | 2007-11-15 | — | — | WO | disclosed |
| US-20070259475-A1 | METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-08 | — | — | US | disclosed |
| WO-2007093643-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007074137-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2007-07-05 | — | — | WO | disclosed |
| CN-1638757-A | Cathepsin cysteine protease inhibitors | MERCK FROSST CANADA INC (CA) | 2005-07-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO2B1, SLC43A3 | CYP2A6 24/4885ALDH1A1 1455/4885HPGD 841/4885 |
| US-20150333275-A1 | TRIANGULENE OLIGOMERS AND POLYMERS AND THEIR USE AS HOLE CONDUCTING MATERIAL | BECN1, TRPA1, TRPV5 | CYP2A6 4405/4885ALDH1A1 2379/4885HPGD 2735/4885 |
| US-20080090325-A1 | METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS | POF1B, RCOR1, RCOR3 | CYP2A6 1816/4885ALDH1A1 2474/4885HPGD 3848/4885 |
| US-20080017850-A1 | applying n-type organic semiconducting compound 1,6,7,12-Tetrachloro-N,N'-benzyl-perylene-3,9; 11,12-tetracarboxylic diimide or 1,6,7,12-tetrachloroperylen-3,9; 9,10-tetracarboxylic dianhydride; charge transfer compounds for electronics, optoelectronics and photonic applications; chemical intermediates | POF1B, NR2C2, NR2E1 | CYP2A6 2078/4885ALDH1A1 2033/4885HPGD 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.